5-Hydroxytryptamine-Mediated neurotransmission modulates Spontaneous and Vagal-Evoked glutamate release in the Nucleus of the solitary tract effect of uptake blockade

Patrick S. Hosford, Steve W. Mifflin, Andrew G. Ramage

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The effect of blockade of either 5-hydroxytryptamine (5-HT)/ serotonin transporter (SERT) with citalopram or the organic cation transporter 3 (OCT3)/plasma membrane monoamine transporter (PMAT) with decynium-22 (D-22) on spontaneous and evoked release of 5-HT in the nucleus tractus solitarius (NTS) was investigated in rat brainstem slices treated with gabazine. 5-HT release was measured indirectly by changes in the frequency and amplitude of glutamatergic miniature excitatory postsynaptic currents (mEPSCs) [in the presence of tetrodotoxin (TTX)] and evoked EPSCs. Blockade of 5-HT3 receptors with granisetron reduced, whereas the 5-HT3 agonist phenylbiguanide increased, the frequency of mEPSCs. 5-HT decreased mEPSC frequency at low concentrations and increased frequency at high concentrations. This inhibition was blocked by the 5-HT1A antagonist N-[2-[4-(2-methoxyphenyl)-1- piperazinyl]ethyl]-N-2- pyridinylcyclohexanecarboxamide (WAY- 100635), which was ineffective on its own, whereas the excitation was reversed by granisetron. The addition of citalopram or D-22 caused inhibition, which was prevented by 5-HT1A blockade. Thus, in the NTS, the spontaneous release of 5-HT is able to activate 5-HT3 receptors, but not 5-HT1A receptors, as the release in their vicinity is removed by uptake. The ineffectiveness of corticosterone suggests that the low-Affinity, high-capacity transporter is PMAT, not OCT3. For evoked 5-HT release, only D-22 caused an increase in the amplitude of EPSCs, with a decrease in the paired pulse ratio, and increased the number of spontaneous EPSCs after 20-Hz stimulation. Thus, for the evoked release of 5-HT, the low-Affinity, high-capacity transporter PMAT, but not 5-HT transporter (5-HTT)/SERT, is important in the regulation of changes in 5-HT extracellular concentration.

Original languageEnglish
Pages (from-to)288-296
Number of pages9
JournalJournal of Pharmacology and Experimental Therapeutics
Volume349
Issue number2
DOIs
StatePublished - May 2014

Fingerprint

Solitary Nucleus
Synaptic Transmission
Glutamic Acid
Serotonin
Membrane Transport Proteins
Excitatory Postsynaptic Potentials
Granisetron
Receptors, Serotonin, 5-HT3
Serotonin Plasma Membrane Transport Proteins
Citalopram
Cell Membrane
Cations
Serotonin 5-HT3 Receptor Agonists
Serotonin 5-HT1 Receptor Antagonists
Receptor, Serotonin, 5-HT1A
Tetrodotoxin
Corticosterone
Brain Stem

Cite this

@article{63459ee201644f6a9aa3a0e23e5c7319,
title = "5-Hydroxytryptamine-Mediated neurotransmission modulates Spontaneous and Vagal-Evoked glutamate release in the Nucleus of the solitary tract effect of uptake blockade",
abstract = "The effect of blockade of either 5-hydroxytryptamine (5-HT)/ serotonin transporter (SERT) with citalopram or the organic cation transporter 3 (OCT3)/plasma membrane monoamine transporter (PMAT) with decynium-22 (D-22) on spontaneous and evoked release of 5-HT in the nucleus tractus solitarius (NTS) was investigated in rat brainstem slices treated with gabazine. 5-HT release was measured indirectly by changes in the frequency and amplitude of glutamatergic miniature excitatory postsynaptic currents (mEPSCs) [in the presence of tetrodotoxin (TTX)] and evoked EPSCs. Blockade of 5-HT3 receptors with granisetron reduced, whereas the 5-HT3 agonist phenylbiguanide increased, the frequency of mEPSCs. 5-HT decreased mEPSC frequency at low concentrations and increased frequency at high concentrations. This inhibition was blocked by the 5-HT1A antagonist N-[2-[4-(2-methoxyphenyl)-1- piperazinyl]ethyl]-N-2- pyridinylcyclohexanecarboxamide (WAY- 100635), which was ineffective on its own, whereas the excitation was reversed by granisetron. The addition of citalopram or D-22 caused inhibition, which was prevented by 5-HT1A blockade. Thus, in the NTS, the spontaneous release of 5-HT is able to activate 5-HT3 receptors, but not 5-HT1A receptors, as the release in their vicinity is removed by uptake. The ineffectiveness of corticosterone suggests that the low-Affinity, high-capacity transporter is PMAT, not OCT3. For evoked 5-HT release, only D-22 caused an increase in the amplitude of EPSCs, with a decrease in the paired pulse ratio, and increased the number of spontaneous EPSCs after 20-Hz stimulation. Thus, for the evoked release of 5-HT, the low-Affinity, high-capacity transporter PMAT, but not 5-HT transporter (5-HTT)/SERT, is important in the regulation of changes in 5-HT extracellular concentration.",
author = "Hosford, {Patrick S.} and Mifflin, {Steve W.} and Ramage, {Andrew G.}",
year = "2014",
month = "5",
doi = "10.1124/jpet.113.211334",
language = "English",
volume = "349",
pages = "288--296",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

5-Hydroxytryptamine-Mediated neurotransmission modulates Spontaneous and Vagal-Evoked glutamate release in the Nucleus of the solitary tract effect of uptake blockade. / Hosford, Patrick S.; Mifflin, Steve W.; Ramage, Andrew G.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 349, No. 2, 05.2014, p. 288-296.

Research output: Contribution to journalArticle

TY - JOUR

T1 - 5-Hydroxytryptamine-Mediated neurotransmission modulates Spontaneous and Vagal-Evoked glutamate release in the Nucleus of the solitary tract effect of uptake blockade

AU - Hosford, Patrick S.

AU - Mifflin, Steve W.

AU - Ramage, Andrew G.

PY - 2014/5

Y1 - 2014/5

N2 - The effect of blockade of either 5-hydroxytryptamine (5-HT)/ serotonin transporter (SERT) with citalopram or the organic cation transporter 3 (OCT3)/plasma membrane monoamine transporter (PMAT) with decynium-22 (D-22) on spontaneous and evoked release of 5-HT in the nucleus tractus solitarius (NTS) was investigated in rat brainstem slices treated with gabazine. 5-HT release was measured indirectly by changes in the frequency and amplitude of glutamatergic miniature excitatory postsynaptic currents (mEPSCs) [in the presence of tetrodotoxin (TTX)] and evoked EPSCs. Blockade of 5-HT3 receptors with granisetron reduced, whereas the 5-HT3 agonist phenylbiguanide increased, the frequency of mEPSCs. 5-HT decreased mEPSC frequency at low concentrations and increased frequency at high concentrations. This inhibition was blocked by the 5-HT1A antagonist N-[2-[4-(2-methoxyphenyl)-1- piperazinyl]ethyl]-N-2- pyridinylcyclohexanecarboxamide (WAY- 100635), which was ineffective on its own, whereas the excitation was reversed by granisetron. The addition of citalopram or D-22 caused inhibition, which was prevented by 5-HT1A blockade. Thus, in the NTS, the spontaneous release of 5-HT is able to activate 5-HT3 receptors, but not 5-HT1A receptors, as the release in their vicinity is removed by uptake. The ineffectiveness of corticosterone suggests that the low-Affinity, high-capacity transporter is PMAT, not OCT3. For evoked 5-HT release, only D-22 caused an increase in the amplitude of EPSCs, with a decrease in the paired pulse ratio, and increased the number of spontaneous EPSCs after 20-Hz stimulation. Thus, for the evoked release of 5-HT, the low-Affinity, high-capacity transporter PMAT, but not 5-HT transporter (5-HTT)/SERT, is important in the regulation of changes in 5-HT extracellular concentration.

AB - The effect of blockade of either 5-hydroxytryptamine (5-HT)/ serotonin transporter (SERT) with citalopram or the organic cation transporter 3 (OCT3)/plasma membrane monoamine transporter (PMAT) with decynium-22 (D-22) on spontaneous and evoked release of 5-HT in the nucleus tractus solitarius (NTS) was investigated in rat brainstem slices treated with gabazine. 5-HT release was measured indirectly by changes in the frequency and amplitude of glutamatergic miniature excitatory postsynaptic currents (mEPSCs) [in the presence of tetrodotoxin (TTX)] and evoked EPSCs. Blockade of 5-HT3 receptors with granisetron reduced, whereas the 5-HT3 agonist phenylbiguanide increased, the frequency of mEPSCs. 5-HT decreased mEPSC frequency at low concentrations and increased frequency at high concentrations. This inhibition was blocked by the 5-HT1A antagonist N-[2-[4-(2-methoxyphenyl)-1- piperazinyl]ethyl]-N-2- pyridinylcyclohexanecarboxamide (WAY- 100635), which was ineffective on its own, whereas the excitation was reversed by granisetron. The addition of citalopram or D-22 caused inhibition, which was prevented by 5-HT1A blockade. Thus, in the NTS, the spontaneous release of 5-HT is able to activate 5-HT3 receptors, but not 5-HT1A receptors, as the release in their vicinity is removed by uptake. The ineffectiveness of corticosterone suggests that the low-Affinity, high-capacity transporter is PMAT, not OCT3. For evoked 5-HT release, only D-22 caused an increase in the amplitude of EPSCs, with a decrease in the paired pulse ratio, and increased the number of spontaneous EPSCs after 20-Hz stimulation. Thus, for the evoked release of 5-HT, the low-Affinity, high-capacity transporter PMAT, but not 5-HT transporter (5-HTT)/SERT, is important in the regulation of changes in 5-HT extracellular concentration.

UR - http://www.scopus.com/inward/record.url?scp=84898794721&partnerID=8YFLogxK

U2 - 10.1124/jpet.113.211334

DO - 10.1124/jpet.113.211334

M3 - Article

C2 - 24618127

AN - SCOPUS:84898794721

VL - 349

SP - 288

EP - 296

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -